Skip to main content
SpringerLink
Log in
Book cover

Therapie der Hautkrankheiten pp 487–511Cite as

Vaskulitis

  • Chapter

  • 228 Accesses

Zusammenfassung

Unter dem klinischen Begriff kutane Vaskulitis wird ein weites Spektrum von Dermatosen verstanden, deren gemeinsames Merkmal histologische Entzündungszeichen an den Hautgefäßen und Veränderungen im umliegenden perivaskulären Gewebe sind.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   299.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   378.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Ammirati CT, Hruza GJ (1999) Treatment of granuloma faciale with the 585-nm pulsed dye laser. Arch Dermatol 135:903–905

    Article  PubMed  CAS  Google Scholar 

  • Blanco R, Martinez-Taboada VM, Rodriguez-Valverde V, Garcia-Fuentes M (1998) Cutaneous vasculitis in children and adults. Medicine 77: 403–418

    Article  PubMed  CAS  Google Scholar 

  • Boom BW, Mommaas AM, Vermeer BJ (1992) Presence and interpretation of vascular immune deposits in human skin: the value of direct immunofluorescence. J Dermatol Sci 3: 26–34

    Article  PubMed  CAS  Google Scholar 

  • Callen JP (1985) Colchicine is effective in controlling chronic cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol 13:193–200

    Article  PubMed  CAS  Google Scholar 

  • Cohen P, Tri Nguyen Q, Ferriére F et al. (1996) Treatment of mixed cryoglobulinemia with recombinant interferon alpha and adjuvant therapies. Ann Med Intern (Paris) 147: 81–86

    CAS  Google Scholar 

  • DeVita S, Neri R, Bombardieri S (1991) Cyclophosphamide pulses in the treatment of rheumatic diseases: an update. Clin Exp Rheumatol 9:179–193

    PubMed  Google Scholar 

  • Dinarello CA (1992) Interleukin-1 and tumor necrosis factor: effector cytokines in autoimmune diseases. Semin Immunol 4:133–145

    PubMed  CAS  Google Scholar 

  • Dowlati B, Firooz A, Dowlati Y (1997) Granuloma faciale: successful treatment of nine cases with a combination of cryotherapy and intralesional corticosteroid injection. Int J Dermatol 36:548–551

    Article  PubMed  CAS  Google Scholar 

  • Dronda F, Gonzalez-Lopez A, Lecona M, Barros C (1996) Erythema elevatum diutinum in human immunodeficiency virus-infected patients- report of a case and review of the literature. Clin Exp Dermatol 21: 222–225

    Article  PubMed  CAS  Google Scholar 

  • Duquesnoy B (1991) Henoch-Schönlein purpura. Baillieres Clin Rheumatol 5: 253–261

    Article  PubMed  CAS  Google Scholar 

  • Fauci AS, Haynes BR, Costa J et al. (1982) Lymphomatoid granulomatosis. Prospective, clinical and therapeutic experience over 10 years. N Engl J Med 306:68–74

    Article  PubMed  CAS  Google Scholar 

  • Ferri C, Marzo E, Longombardo G et al. (1993) Interferonalpha in mixed cryoglobulinemia patients: a randomized, cross over controlled trial. Blood 81:1132–1136

    PubMed  CAS  Google Scholar 

  • Gibson LE, Daniel Su WP (1995) Cutaneous Vasculitis. Rheum Dis Clin North Am 21:1097–1113

    PubMed  CAS  Google Scholar 

  • Goldstein AR, White RHR, Akuse R, Chantier C (1992) Long-term follow up of childhood Henoch-Schönlein nephritis. Lancet 339:280–282

    Article  PubMed  CAS  Google Scholar 

  • Horn T (1985) Long-standing erythematous facial plaques: Granuloma faciale. Arch Dermatol 121:1553–1557

    Article  PubMed  CAS  Google Scholar 

  • James WD, Odom RB, Katzenstein AL (1981) Cutaneous manifestations of lymphomatoid granulomatosis: Report of 44 cases and review of the literature. Arch Dermatol 117:196–202

    Article  PubMed  CAS  Google Scholar 

  • Jennette JC, Falk RJ (1997) Small-vessel vasculitis. N Engl J Med 20:1512–1523

    Article  Google Scholar 

  • Jessop SJ (1995) Cutaneous leucocytoclastic vasculitis: a clinical and aetiological study. Br J Rheumatol 34:942–945

    Article  PubMed  CAS  Google Scholar 

  • Katz SI, Gallin JI, Hertz KC et al. (1977) Erythema elevatum diutinum: Skin and systemic manifestations, immunologic studies, and successful treatment with dapsone. Medicine 56:443–455

    Article  PubMed  CAS  Google Scholar 

  • Korting HCh, Sterry W (Hrsg) (2000) Therapeutische Verfahren in der Dermatologie: Dermatika und Kosmetika. Blackwell

    Google Scholar 

  • Lotti T, Ghersetich I, Comacchi C, Jorizzo JL (1998) Cutaneous small-vessel vasculitis. J Am Acad Dermatol 39: 667–687

    Article  PubMed  CAS  Google Scholar 

  • McCune WJ, Friedman AW (1992) Immunosuppressive drug therapy for rheumatic disease. Curr Opin Rheumatol 4: 314–312

    Article  PubMed  CAS  Google Scholar 

  • Mertz LE, Conn DL (1992) Vasculitis associated with malignancy. Curr Opin Rheumatol 4:39–46

    PubMed  CAS  Google Scholar 

  • Misiani R, Bellavita P, Fenili D et al. (1994) Interferon alpha-2a therapy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med 330:751–756

    Article  PubMed  CAS  Google Scholar 

  • Mollica F, Li Volti S, Garozzo R, Russo G (1992) Effectiveness of early prednisolone treatment in preventing the development of nephropathy in anaphylactoid purpura. Eur J Pediatr 151:140–144

    Article  PubMed  CAS  Google Scholar 

  • Muratori S, Carrera C, Gorani A, Alessi E (1999) Erythema elevatum diutinum and HIV infection: a report of five cases. Br J Dermatol 141:335–338

    Article  PubMed  CAS  Google Scholar 

  • Sanchez NP, Van Hale HM, Su WPD (1985) Clinical and histopathological spectrum of necrotizing vasculitis: Report of findings in 101 cases. Arch Dermatol 121: 220–224

    Article  PubMed  CAS  Google Scholar 

  • Stadler R, Ruszczak Z (1995) Therapeutic guidelines in vasculitis. Int Angiol 14:187–196

    Google Scholar 

  • Szer IS (1996) Henoch-Schönlein Purpura: When and how to treat? J Rheumatol 23:1661–1665

    PubMed  CAS  Google Scholar 

  • Vente C, Rupprecht R, Oestermann E, Menzel S, Neumann C (1998) Granuloma eosinophilicum faciei — successful cryosurgery treatment of 6 patients. Hautarzt 49:477–481

    Article  PubMed  CAS  Google Scholar 

  • Volkenandt M, Kerscher M, Sander C, Meurer M, Röcken M (1995) PUVA-bath photochemotherapy resulting in rapid clearance of lymphomatoid papulosis in a child. Arch Dermatol 131:1094

    Article  PubMed  CAS  Google Scholar 

  • Vonderheid EC, Sajjadian A, Kadin ME (1996) Methotrexate is an effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders. J Am Acad Dermatol 34: 470–481

    Article  PubMed  CAS  Google Scholar 

  • Wilkinson SM, English JSC, Smith NP et al. (1992) Erythema elevatum diutinum: A clinicopathological study. Clin Exp Dermatol 17: 87–93

    Article  PubMed  CAS  Google Scholar 

  • Willemze R (1985) Lymphomatoid papulosis. Dermatol Clin 3:735–747

    PubMed  CAS  Google Scholar 

  • Wyss M, Dummer R, Dommann SN, Joller-Jemelka HI, Dours-Zimmermann MT, Gilliet F, Burg G (1995) Lymphomatoid papulosis- treatment with recombinant interferon alfa-2a and etretinate. Dermatology 190: 288–291

    Article  PubMed  CAS  Google Scholar 

  • Abu-Elmagd K, Van Thiel DH, Jegasothy BV et al. (1993) Resolution of severe pyoderma gangrenosum in a patient with streaking leukocyte factor disease after treatment with tacrolimus (FK 506). Ann Intern Med 119:595–598

    Article  PubMed  CAS  Google Scholar 

  • Arbiser JL, Moschella SL (1995) Clofazimine: A review of its medical uses and mechanisms of action. J Am Acad Dermatol 32:241–247

    Article  PubMed  CAS  Google Scholar 

  • Callen JP (1998) Pyoderma gangraenosum. Lancet 351:581–85

    Article  PubMed  CAS  Google Scholar 

  • Chow RKP, Ho VC (1996) Treatment of pyoderma gangraenosum. J Am Acad Dermatol 34:1047–60

    Article  PubMed  CAS  Google Scholar 

  • Elgart G, Stover P, Larson K et al. (1991) Treatment of pyoderma gangrenosum with cyclosporine: Results in seven patients. J Am Acad Dermatol 24: 83–86

    Article  PubMed  CAS  Google Scholar 

  • Giessen M, Gründer K, Schill W-B (1994) Erfolgreiche Behandlung der Pyoderma gangraenosum mit Clofazimine. Z Hautkr 69:399–402

    Google Scholar 

  • Sanders CJG ,Hulsmans RFHJ (1993) Successful treatment of pyoderma gangrenosum with tropical 5-aminosalicylic acid. Cutis 51: 262–264

    PubMed  CAS  Google Scholar 

  • Bohn S, Buchner S, Itin P (1997) Erythema nodosum. 112 cases: epidemiology, clinical aspects and histopathology. Schweiz Med Wochenschr 127:1168–1176

    PubMed  CAS  Google Scholar 

  • Cho KH, Lee DY, Kim CW (1996) Erythema induratum of Bazin. Int J Dermatol 35: 802–808

    Article  PubMed  CAS  Google Scholar 

  • Cribier B, Caille A, Heid E, Grosshans E (1998) Erythema nodosum and associated diseases. A study of 129 cases. Int J Dermatol 37: 667–672

    Article  PubMed  CAS  Google Scholar 

  • Horio T, Danno K, Okamoto H et al. (1983) Potassium iodide in erythema nodosum and other erythematous dermatosis. J Am Acad Dermatol 9:77–81

    Article  PubMed  CAS  Google Scholar 

  • Psychos DN, Voulgari PV, Skopouli FN, Drosos AA, Moutso-poulos HM (2000) Erythema nodosum: the underlying conditions, clin Rheumatol 19: 212–216

    Article  CAS  Google Scholar 

  • Schaffer N, Kerdel FA (1991) Nodular vasculitis (erythema induratum): treatment with auranofin. J Am Acad Dermatol 25:426–429

    Article  Google Scholar 

  • Ubogy Z, Persellin RH (1982) Suppression of erythema nodosum by indomethacin. Acta Derm Venereol 62:265–267

    PubMed  CAS  Google Scholar 

  • Bisalbutra P, Kullavanijaya P (1993) Sulfasalazine in atrophie blanche. J Am Acad Dermatol 28: 275–276

    Article  PubMed  CAS  Google Scholar 

  • Drucker CR, Duncan WC (1982) Antiplatelet therapy in atrophie blanche and livedo vasculitis. J Am Acad Dermatol 7:359–363

    Article  PubMed  CAS  Google Scholar 

  • Hsiao GH, Chiu HC (1997) Low-dose danazol in the treatment of livedoid vasculitis. Dermatology 194: 251–255

    Article  PubMed  CAS  Google Scholar 

  • Jetton RL, Lazarus GS (1983) Minidose heparin therapy for vasculitis of atropine blanche. J Am Acad Dermatol 8:23–26

    Article  PubMed  CAS  Google Scholar 

  • Milestone LM, Braverman IM, Lucky P, Fleckman P (1983) Classification and therapy of atrophie blanche. Arch Dermatol 119:963–969

    Article  Google Scholar 

  • Purcell SM, Hayes TJ (1986) Nifedipine treatment of idiopathic atrophie blanche. J Am Acad Dermatol 14:851–854

    Article  PubMed  CAS  Google Scholar 

  • Sams MW (1988) Livedo vasculitis. Therapy with Pentoxifyllin. Arch Dermatol 124: 684–687

    Article  PubMed  Google Scholar 

  • Sauer GC (1986) Pentoxifylline (Trental) therapy for the vasculitis of atrophie blanche. Arch Dermatol 122:380–381

    Article  PubMed  CAS  Google Scholar 

  • Wakelin SH, Ellis JP, Black MM (1998) Livedoid vasculitis with anticardiolipin antibodies: improvement with danazol. Br J Dermatol 139:935–937

    Article  PubMed  CAS  Google Scholar 

  • Alegre VA, Winkelmann RK, Gastineau DA (1990) Cutaneous thrombosis, cerebrovascular thrombosis and lupus anticoagulant — the Sneddon syndrome. Int J Dermatol 29: 45–49

    Article  PubMed  CAS  Google Scholar 

  • Baumann M, Tebbe B, Arnold M, Krengel S, Goerdt S, Orfanos CE (2000) Livedo racemosa: Ungewöhnliche Spätmanifestation einer Borreliose? Hautarzt 51:593–596

    Article  PubMed  CAS  Google Scholar 

  • Deffer TA, Berger TG, Gelinas-Sorell D (1987) Sneddon’s syndrome. J Am Acad Dermatol 16:1084–1087

    Article  Google Scholar 

  • Falanga V, Fine MJ, Kapoor WN (1986) The cutaneous manifestations of cholesterol embolization. Arch Dermatol 112:1194–1198

    Article  Google Scholar 

  • Frances C, Papo T, Wechsler B, Laporte JL, Biousse V, Piette JC (1999) Sneddon Syndrome with or without Antiphos-pholipid Antibodies. Medicine 78: 209–219

    Article  PubMed  CAS  Google Scholar 

  • Gollnick H, Cerda JH, Bradac GB (1985) Livedo racemosa generalisata (Ehrmann) mit cerebrovaskulärer Beteiligung (Herman-Sneddon). Akt Dermatol 11:17–21

    Google Scholar 

  • Lubach D, Stamm T, Schwabe C et al. (1990) Livedo racemosa generalisata — an evaluation of thirty-four cases. J Am Acad Dermatol 22: 633–639

    Article  PubMed  CAS  Google Scholar 

  • Stephens CJ (1992) Sneddon’s syndrome. Clin Exp Rheumatol 10:489–492

    PubMed  CAS  Google Scholar 

  • Stockhammer G, Felber SR, Zeiger B (1993) Sneddon’s syndrome: diagnosis by skin biopsy and MRI in 17 patients. Stroke 24: 685–690

    Article  PubMed  CAS  Google Scholar 

  • Zeiger B, Sepp N, Stockhammer G et al. (1993) Sneddon’s syndrome: a long-term follow-up of 21 patients. Arch Dermatol 129:437–447

    Article  Google Scholar 

  • Alegre VA, Gastineau DA, Winkelmann RK (1989) Skin lesions associated with circulating lupus anticoagulant. Br J Dermatol 120:419–429

    Article  PubMed  CAS  Google Scholar 

  • Asherson RA (1998) The catastrophic antiphospholipid syndrome, 1998. A review of the clinical features, possible pathogenesis and treatment. Lupus 7 Suppl: S55–62

    Google Scholar 

  • Bick RL, Arun B, Frenkel EP (1999) Antiphospholipid-thrombosis syndromes. Haemostasis 29:100–110

    PubMed  CAS  Google Scholar 

  • Blentry 0, Blanc AS, Piette AM (1999) Value of intravenous immunoglobulins during antiphospholipid syndrome. Rev Med Interne 20:410S-413 s

    Article  Google Scholar 

  • Grattan CE, Burton JL (1991) Antiphospholipid syndrome and cutaneous vasoocclusive disorders. Semin Dermatol 10:152–159

    PubMed  CAS  Google Scholar 

  • Greaves M (1999) Antiphospholipid antibodies and thrombosis. Lancet 17:1348–1353

    Article  Google Scholar 

  • Naldi L, Locati F, Marchesi L et al. (1993) Cutaneous manifestations associated with antiphospholipid antibodies in patients with suspected primary antiphospholipid syndrome: a case-control study. Ann Rheum Dis 52:219–222

    Article  PubMed  CAS  Google Scholar 

  • Petri M (1997) Pathogenesis and treatment of the antiphospholipid antibody syndrome. Med Clin North Am 81:151–177

    Article  PubMed  CAS  Google Scholar 

  • Tebbe B, Orfanos CE (1992) Antikardiolipin — Antikörper beim kutanen Lupus erythematodes. Vorkommen und Bedeutung als Marker vaskulärer Symptomatik Hautarzt 42:130–133

    Google Scholar 

  • Zouboulis ChC, Büttner P, Tebbe B, Orfanos CE (1993) Anticardiolipin antibodies in Adamantiades-Behçet’s disease. Br J Dermatol 128: 281–294

    Article  PubMed  CAS  Google Scholar 

  • Diaz-Perez JL, Winkelmann RK (1980) Cutaneous periarteritis nodosa: A study of 33 cases. In Wolff K, Winkelmann RK (eds) Major problems in dermatology. Saunders, Philadelphia, 273 pp

    Google Scholar 

  • Gayraud M, Guillevin L, Ie Toumelin P et al. (2001) Longterm followup of polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: analysis of four prospective trials includingg 278 patients. Arthritis Rheum 44: 666–675

    Article  PubMed  CAS  Google Scholar 

  • Gross WL (1994) New developments in the treatment of systemic vasculitis. Curr Opin Rheumatol 6:11–19

    Article  PubMed  CAS  Google Scholar 

  • Guillevin L, Fain O, Lhote F et al. (1992) Lack of superiority of steroid plus plasma exchange to steroids alone in the treatment of polyarteritis nodosa and Churg-Strauss-Syndrom. Arthritis Rheum 35:208–215

    Article  PubMed  CAS  Google Scholar 

  • Guillevin L, Lhote F, Cohen P et al. (1995) Polyarteritis nodosa related to hepatitis B virus: a pospective study with long-term observation of 41 patients. Medicine (Baltimore) 74: 238–253

    Article  CAS  Google Scholar 

  • Guillevin L, Lhote F, Gayraud M et al. (1996) Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome: a prospective study in 342 patients. Medicine (Baltimore) 75:17–28

    Article  CAS  Google Scholar 

  • Thomas RH, Meyrick, Black MM (1983) The wide clinical spectrum of periarteritis nodosa with cutaneous involvement. Clin Exp Dermatol 8:47–59

    Article  PubMed  CAS  Google Scholar 

  • Abdullah AN, Keczkes K, Wyatt EH (1989) Skin necrosis in giant cell (temporal) arteritis: Report of three cases. Br J Dermatol 120: 843–846

    Article  PubMed  CAS  Google Scholar 

  • Braun EW, Sams WM, Payne RR (1982) Giant cell arteritis: a systemic disease with rare cutaneous manifestations. J Am Acad Dermatol 6:1081–1088

    Article  Google Scholar 

  • Doury P, Fabresse FX, Pattin S et al. (1984) La place de la dapsone dans le traitement de la maladie de Horton et de la pseudopolyarthrite rhizomelique. Ann Med Interne (Paris) 135:31–35

    CAS  Google Scholar 

  • Hall S, Barr W, Lie JT et al. (1985) Takayasu arteritis. A study of 32 North American patients. Medicine 64: 89–99

    Article  PubMed  CAS  Google Scholar 

  • Hitch JM (1970) Dermatologic manifestations of giant-cell (temporal, cranial) arteritis. Arch Dermatol 101: 409–415

    Article  PubMed  CAS  Google Scholar 

  • Hunder GG (1997) Giant cell arteritis and polymyalgia rheumatica. Med Clin North Am 81:195–219

    Article  PubMed  CAS  Google Scholar 

  • Liozon F, Vidal E, Bonnetblanc JM et al. (1986) Disulon in the treatment of Horton’s disease. Experience with 20 patients. Ann Med Interne (Paris) 137:299–306

    CAS  Google Scholar 

  • Perniciaro CV, Winkelmann RK, Hunder GG (1987) Cutaneous manifestations of Takayasu’s arteritis: A clinicopathologic correlation. J Am Acad Dermatol 17: 998–1005

    Article  PubMed  CAS  Google Scholar 

  • Brandwein S, Esdaile J, Daniff D et al. (1983) Wegener’s granulomatosis: clinical features and outcome in 13 patients. Ann Intern Med 143:476–479

    Article  CAS  Google Scholar 

  • DeRemee RA, McDonald TJ, Weiland LH (1985) Wegener’s granulomatosis: observation and treatment with antimicrobial agents. Mayo Clin Proc 60: 27–32

    Article  Google Scholar 

  • DeRemee RA, McDonald TJ, Weiland LH (1987) Aspekte zur Therapie und Verlaufsbeobachtung der Wegener’schen Granulomatose. Med Welt 38:470–473

    Google Scholar 

  • Duna GF, Galperin C, Hoffmann GS (1995) Wegener’s granulomatosis. Rheum Dis Clin North Am 21:949–986

    PubMed  CAS  Google Scholar 

  • Fauci AS, Haynes BF, Katz P, Wolff SM (1983) Wegener’s granulomatosis: prospective clinical therapeutic experience with 85 patients for 21 years. Ann Intern Med 98:76–85

    Article  PubMed  CAS  Google Scholar 

  • Gaskin G, Savage CO, Ryan JJ (1991) Anti-neutrophil cytoplasmic antibodies and disease activity during longterm follow-up of 70 patients with systemic vasculitis. Nephrol Dial Transplant 6: 689–694

    Article  PubMed  CAS  Google Scholar 

  • Gross WL (1997) Systemic necrotizing vasculitis. Baillière’s Clin Rheumatol 11:259:284

    Google Scholar 

  • Groot de K, Gross WL (1998) Wegener’s granulomatosis: disease course, assessment of activity, extent and treatment. Lupus 7:285–291

    Article  PubMed  Google Scholar 

  • Hagen EC, Ballieux BE PB, Daha MR et al. (1992) Fundamental and clinical aspects of antineutrophil cytoplasmic antibodies (ANCA). Autoimmunity 11:199–207

    Article  PubMed  CAS  Google Scholar 

  • Hagen EC, Ballieux BEPB, Es van LA et al. (1993) Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenic consequences. Blood 81:1996–2002

    PubMed  CAS  Google Scholar 

  • Hoffmann GS, Kerr GS, Leavitt RY et al. (1992) Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 116:488–498

    Article  Google Scholar 

  • Hu CH, O’Loughlin S, Winkelmann RK (1977) Cutaneous manifestations of Wegener’s granulomatosis. Arch Dermatol 113:175–182

    Article  PubMed  CAS  Google Scholar 

  • Israel HL (1988) Sulfamethoxazol-trimethoprim therapy for Wegener’s granulomatosis. Arch Intern Med 148:2293–2295

    Article  PubMed  CAS  Google Scholar 

  • Jayne DR, Lockwood CM (1993) Pooled intravenous immunoglobulin in the management of systemic vasculitis. Adv Exp Med Biol 336:469–472

    PubMed  CAS  Google Scholar 

  • Mahr A, Girard T, Agher R, Guillevin L (2001) Analysis of factors predictive of suvival based on 49 patients with systemic Wegener’s granulomatosis and prospective follow-up. Rheumatology 40:492–498

    Article  PubMed  CAS  Google Scholar 

  • Novack SN, Pearson CM (1971) Cyclophosphamide therapy in Wegener’s granulomatosis. N Engl J Med 284:938–942

    Article  PubMed  CAS  Google Scholar 

  • Raitt JW (1971) Wegener’s granulomatosis: Treatment with cytotoxic agents and adrenocorticoids. Ann Intern Med 74:344–356

    Article  PubMed  CAS  Google Scholar 

  • Richter C, Schnabel A, Csernok E, De Groot K, Reinhold-Keller E, Gross WL (1995) Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin. Clin Exp Immunol 101: 2–7

    Article  PubMed  CAS  Google Scholar 

  • Savage COS, Harper L, Adu D (1997) Primary systemic vasculitis. Lancet 349:553–558

    Article  PubMed  CAS  Google Scholar 

  • Specks S, Wheatley CL, McDonald TJ et al. (1989) Anticytoplasmic autoantibodies in the diagnosis and follow-up of Wegener’s granulomatosis. Mayo Clin Proc 64: 28–36

    Article  PubMed  CAS  Google Scholar 

  • Stegemann CA, Tervaert JWC, Jong de PE, Kallenberg CGM (1996) Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. N Engl J Med 335:16–20

    Article  Google Scholar 

  • Steppat D, Gross WL (1989) Stage-adapted treatment of Wegener’s granulomatosis. First results of a prospective study. Klin Wochenschr 67: 666–671

    Article  PubMed  CAS  Google Scholar 

  • Thomas RH, Payne CM, Black MM (1982) Wegener’s granulomatosis presenting as pyoderma gangrenosum. Clin Exp Dermatol 7:523–527

    Article  PubMed  CAS  Google Scholar 

  • Weiner SR, Paulus HE (1989) Treatment of Wegener’s granulomatosis. Semin Respir Med 10:156–161

    Article  Google Scholar 

  • Chumbley LC, Harrison EG, DeRemee RA (1977) Allergic granulomatosis and angiitis (Churg-Strauss-Syndrom). Report and analysis of 30 cases. Mayo Clin Proc 52:477–484

    PubMed  CAS  Google Scholar 

  • Churg J, Strauss L (1951) Allergic granulomatosis, allergic angiitis, and periarteritis nodosa. Am J Pathol 27:277–301

    PubMed  CAS  Google Scholar 

  • Cottin V, Cordier JF (1999) Churg-Strauss syndrome. Allergy 54:535–551

    Article  PubMed  CAS  Google Scholar 

  • Crotty CP, DeRemee RA, Winkelmann RK (1981) Cutaneous clinicopathologic correlation of allergic granulomatosis. I Am Acad Dermatol 5:571–581

    Article  CAS  Google Scholar 

  • Finan MD, Winkelmann RK (1983) The cutaneous necrotizing granuloma (Churg-Strauss syndrome) and systemic disease: review of 27 cases. Medicine 62:142–158

    Article  PubMed  CAS  Google Scholar 

  • Guillevin L, Lhote F, Gayraud M et al. (1996) Prognostic factors in polyarteritis nodosa and Churg-Strauss syndrome. A prospective study in 342 patients. Medicine (Baltimore) 75:17–28

    Article  CAS  Google Scholar 

  • Haas C, Geneau C, Odinot JM (1991) L’angeite allergique avec granulomatose: syndrome de Churg et Strauss. Ann Med Interne (Paris) 142:335–342

    CAS  Google Scholar 

  • Langford CA (1997) Chronic immunosuppressive therapy for systemic vasculitis. Curr Opin Rheumatol 9:41–47

    Article  PubMed  CAS  Google Scholar 

  • Lanham JG, Elkon KB, Pusey CD, Hughes GR (1984) Systemic vasculitis with asthma and eosinophilia: a clinical approach to the Churg-Strauss syndrome. Medicine 63: 65–81

    Article  PubMed  CAS  Google Scholar 

  • McDermott EM, Powell RJ (1998) Cyclosporin in the treatment of Churg-Strauss syndrome. Ann Rheum Dis 57: 258–259

    Article  PubMed  CAS  Google Scholar 

  • Sneller MC (1998) Evaluation, treatment, and prophylaxis of infections complicating systemic vasculitis. Curr Opin Rheumatol 10:38–44

    Article  PubMed  CAS  Google Scholar 

  • Specks U, DeRemee RA (1990) Granulomatous vasculitis: Wegener’s granulomatosis and Churg-Strauss syndrome. Rheum Dis Clin North Am 16:377–397

    PubMed  CAS  Google Scholar 

  • Tatsis E, Schnabel A, Gross WL (1998) Interferon-alpha treatment of four patients with the Churg-Strauss syndrome. Ann Intern Med 129:370–374

    Article  PubMed  CAS  Google Scholar 

  • Csernok E, Gross WL (1995) Antineutrophile zytoplasmatische Antikörper (ANCA) bei entzündlichen rheumatischen Erkrankungen: immundiagnostische und immunpathogenetische Aspekte. Z Rheumatol 54:26–38

    PubMed  CAS  Google Scholar 

  • Csernok E, Schmitt WH, Ernst M et al. (1993) Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides. Adv Exp Med Biol 336:45–50

    PubMed  CAS  Google Scholar 

  • Ellis EN, Wood EG, Berry P (1995) Spectrum of disease associated with anti-neutrophil cytoplasmic autoantibodies in pediatric patients. J Pediatr 126:40–43

    Article  PubMed  CAS  Google Scholar 

  • Gaudin PB, Askin FB, Falk RJ, Jennette JC (1995) The pathologic spectrum of pulmonary lesions in patients with anti-neutrophil cytoplasmic autoantibodies specific for anti-proteinase 3 and anti-myeloperoxidase. Am J Clin Pathol 104:7–16

    PubMed  CAS  Google Scholar 

  • Gross WL, Schmitt WH (1995) ANCA-assoziierte Vaskulitiden. Hautarzt 46:511–524

    Article  PubMed  CAS  Google Scholar 

  • Gross WL, Schmitt WH, Csernok E (1993) ANCA and associated diseases: immunodiagnostic and pathogenetic aspects. Clin Exp Immunol 91:1–12

    Article  PubMed  CAS  Google Scholar 

  • Jennette CJ, Milling DM, Falk RJ (1994) Vasculitis affecting the skin. A review. Arch Dermatol 130: 899–906

    Article  PubMed  CAS  Google Scholar 

  • Jennette JC, Falk RJ (1995) Clinical and pathological classification of ANCA-associated vasculitis: what are the controversies? Clin Exp Immunol 101:18–22

    Article  PubMed  Google Scholar 

  • Kekow J, Csernok E, Szymkowiak CH, Gross WL (1993) Wegenersche Granulomatose und ANCA-assoziierte Vaskulitiden: pathogenetische Konzepte zur Rolle von Autoantigenen, Autoantikörpern und Zytokinen. Immun Infekt 21:44–48

    PubMed  Google Scholar 

  • Richter C, Schnabel A, Csernok E et al. (1995) Treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis with high-dose intravenous immunoglobulin. Clin Exp Immunol 101:2–7

    Article  PubMed  CAS  Google Scholar 

  • Robertson CR, McCallum RM (1994) Changing concepts in pathophysiology of the vasculitides. Curr Opin Rheumatol 6:3–10

    Article  PubMed  CAS  Google Scholar 

  • Savige JA, Chang L, Cook L et al. (1995) Alpha 1antitrypsin deficiency and anti-proteinase 3 antibodies in anti-neutrophil cytoplasmic antibody (ANCA)-associated systemic vasculitis. Clin Exp Immunol 100:194–197

    Article  PubMed  CAS  Google Scholar 

  • Callen JP, Kalbfleisch S (1982) Urticarial vasculitis: A report of nine cases and review of the literature. Br J Dermatol 107: 87–93

    Article  PubMed  CAS  Google Scholar 

  • Dubost JJ, Souteyrand P, Sauvezie B (1991) Drug-induced vasculitides. Baillieres Clin Rheumatol 5:119–138

    Article  PubMed  CAS  Google Scholar 

  • Ekenstam EAF, Callen JP (1984) Cutaneous leukocytoclastic vasculitis: Clinical and laboratory features of 82 patients seen in private practice. Arch Dermatol 120:484–489

    Article  Google Scholar 

  • Gibson LE, Su WP (1990) Cutaneous vasculitis. Rheum Dis Clin North Am 16:309–324

    PubMed  CAS  Google Scholar 

  • Goeken JA (1991) Antineutrophil cytoplasmic antibody — a useful serological marker for vasculitis. J Clin Immunol 11:161–174

    Article  PubMed  CAS  Google Scholar 

  • Jorizzo JL (1993) Classification of vasculitis. J Invest Dermatol 100:106S-110 S

    Article  Google Scholar 

  • Lancet editorial (1988) Factor VIII related antigen and vasculitis. Lancet 1:1203–1204

    Google Scholar 

  • Lawley TJ, Kubota Y (1990) Vasculitis. Dermatol Clin 8: 681–687

    CAS  Google Scholar 

  • Mackel SE (1982) Treatment of vasculitis. Med Clin North Am 66:941–954

    PubMed  CAS  Google Scholar 

  • Mader R, Keystone EC (1992) Infections that cause vasculitis. Curr Opin Rheumatol 4:35–38

    PubMed  CAS  Google Scholar 

  • Monroe EW (1981) Urticarial vasculitis: An updated review. J Am Acad Dermatol 5: 88–95

    Article  PubMed  CAS  Google Scholar 

  • Pusey CD (1990) Plasma exchange in immunological disease. Prog Clin Biol Res 337:419–424

    PubMed  CAS  Google Scholar 

  • Sanchez NP, Van Hale HM, Su WP (1985) Clinical and histopathologic spectrum of necrotizing vasculitis. Report of findings in 101 cases. Arch Dermatol 121:220–224

    Article  PubMed  CAS  Google Scholar 

  • Smoller BR, McNutt NS, Contreras F (1990) The natural history of vasculitis. Arch Dermatol 126:84–89

    Article  PubMed  CAS  Google Scholar 

  • Stephens CJM (1991) The antiphospholipid syndrome. Br J Dermatol 125:199–210

    Article  PubMed  CAS  Google Scholar 

  • Tsokos M, Lazarou SA, Moutsopoulos HM (1987) Vasculitis in primary Sjögren’s syndrome: Histologic classification and clinical presentation. Am J Clin Pathol 88: 26–31

    PubMed  CAS  Google Scholar 

  • Venning MC, Quinn A, Broomhead V, Bird AG (1990) Antibodies directed against neutrophils (C-ANCA and P-ANCA) are of distinct diagnostic value in systemic vasculitis. Q J Med 77:1287–1296

    Article  PubMed  CAS  Google Scholar 

  • Wolff K, Winkelmann RK (1980) Vasculitis. Saunders, Philadelphia

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Dermatologie, Universitätsklinikum Benjamin Franklin Freie Universität Berlin, Fabeckstr. 60-62, 14195, Berlin, Deutschland

    Prof. Dr. Prof. h. c. Constantin E. Orfanos

  2. Hautklinik und Poliklinik, Eberhard-Karls-Universität, Liebermeisterstr. 25, 72076, Tübingen, Deutschland

    Prof. Dr. Claus Garbe

Authors
  1. Prof. Dr. Prof. h. c. Constantin E. Orfanos
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Prof. Dr. Claus Garbe
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

U. Blume-Peytavi C. C. Geilen S. Goerdt H. Gollnick E. Haneke F.-M. Köhn B. Tebbe R. Treudler Ch. C. Zouboulis

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Orfanos, C.E., Garbe, C. (2002). Vaskulitis. In: Blume-Peytavi, U., et al. Therapie der Hautkrankheiten. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56219-8_20

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56219-8_20

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-62541-1

  • Online ISBN: 978-3-642-56219-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation